Javascript must be enabled to continue!
Natural Products as Monoamine Oxidase Inhibitors: Potential Agents for Neurological Disorders
View through CrossRef
Abstract:
The role of medicinal plants has been advantageous due to their manifestation through
various cellular and molecular mechanisms. Inhibition of the monoamine oxidase enzyme is suspected
to be a highly effective treatment for various neurological illnesses like Alzheimer's disease,
Parkinson’s disease, depression, social phobia, and panic disorders. The study of phytochemicals
and plant extracts used as a traditional source of medication revealed that they possess the vast potential
for monoamine oxidase inhibition. Thus, the article focuses on the potential use of plant extracts
and phytochemicals as sources of novel MAO inhibitors for treating neurological disorders.
Exhaustive literature search revealed that a variety of phytochemicals from the categories such as
flavonoids, alkaloids, glycosides, alkyl phenyl ketones, coumarin derivatives and essential oils
have displayed potential MAO inhibition. This review highlights the progress made in the discovery
and development of plant-based MAO inhibitors and aims to provide medicinal chemists with
an overview of this information to aid in the development of clinically viable drugs.
Bentham Science Publishers Ltd.
Title: Natural Products as Monoamine Oxidase Inhibitors: Potential Agents for
Neurological Disorders
Description:
Abstract:
The role of medicinal plants has been advantageous due to their manifestation through
various cellular and molecular mechanisms.
Inhibition of the monoamine oxidase enzyme is suspected
to be a highly effective treatment for various neurological illnesses like Alzheimer's disease,
Parkinson’s disease, depression, social phobia, and panic disorders.
The study of phytochemicals
and plant extracts used as a traditional source of medication revealed that they possess the vast potential
for monoamine oxidase inhibition.
Thus, the article focuses on the potential use of plant extracts
and phytochemicals as sources of novel MAO inhibitors for treating neurological disorders.
Exhaustive literature search revealed that a variety of phytochemicals from the categories such as
flavonoids, alkaloids, glycosides, alkyl phenyl ketones, coumarin derivatives and essential oils
have displayed potential MAO inhibition.
This review highlights the progress made in the discovery
and development of plant-based MAO inhibitors and aims to provide medicinal chemists with
an overview of this information to aid in the development of clinically viable drugs.
Related Results
The Effects of Xanthine Oxidase Inhibitors on the Management of Cardiovascular Diseases
The Effects of Xanthine Oxidase Inhibitors on the Management of Cardiovascular Diseases
Cardiovascular diseases (CVDs) are the fastest-growing cause of death around the world, and atherosclerosis plays a major role in the etiology of CVDs. The most recent figures show...
Therapeutic potential of SGLT-2 inhibitors and DDP4 inhibitors in elderly patients with type 2 diabetes mellitus and benign prostatic hyperplasia
Therapeutic potential of SGLT-2 inhibitors and DDP4 inhibitors in elderly patients with type 2 diabetes mellitus and benign prostatic hyperplasia
Background. Benign prostatic hyperplasia (BPH) has recently been linked to diabetes mellitus and insulin resistance. This study aims to explore whether the use of either sodium-glu...
Efficacy and safety of neoadjuvant PD-1 inhibitors or PD-L1 inhibitors for muscle invasive bladder cancer: a systematic review and meta-analysis
Efficacy and safety of neoadjuvant PD-1 inhibitors or PD-L1 inhibitors for muscle invasive bladder cancer: a systematic review and meta-analysis
IntroductionThis meta-analysis aims to evaluate the efficacy and safety of neoadjuvant PD-1 inhibitors or PD-L1 inhibitors [PD-(L)1 inhibitors] for muscle-invasive bladder carcinom...
Aurone Scaffold and Structural Analogues for the Development of Monoamine Oxidase (MAO) Inhibitors
Aurone Scaffold and Structural Analogues for the Development of Monoamine Oxidase (MAO) Inhibitors
<div>Continuous efforts in the development of monoamine oxidase inhibitors</div><div>prompted the search for effective strategies for the design of novel drugs ca...
Perturbation of monoamine metabolism and enhanced fear responses in mice defective in the regeneration of tetrahydrobiopterin
Perturbation of monoamine metabolism and enhanced fear responses in mice defective in the regeneration of tetrahydrobiopterin
AbstractIncreasing evidence suggests the involvement of peripheral amino acid metabolism in the pathophysiology of neuropsychiatric disorders, whereas the molecular mechanisms are ...
Buy Psychedelic Products Online (Preprint)
Buy Psychedelic Products Online (Preprint)
BACKGROUND
Contact +1 (601) 721-8695
Email sales@psychdistro.com
Address 7777 W 38th Ave A104 Wheat Ridge CO 80033 United States
Looking for the highest-...
[RETRACTED] Keanu Reeves CBD Gummies v1
[RETRACTED] Keanu Reeves CBD Gummies v1
[RETRACTED]Keanu Reeves CBD Gummies ==❱❱ Huge Discounts:[HURRY UP ] Absolute Keanu Reeves CBD Gummies (Available)Order Online Only!! ❰❰= https://www.facebook.com/Keanu-Reeves-CBD-G...
Neurological Symptoms and Cause of Death Among Young Children in Low- and Middle-Income Countries
Neurological Symptoms and Cause of Death Among Young Children in Low- and Middle-Income Countries
ImportanceThe emergence of acute neurological symptoms in children necessitates immediate intervention. Although low- and middle-income countries (LMICs) bear the highest burden of...

